Buy IMIGRAN 50mg Tablet 6s Online At Best Price In Pakistan

Dosage

Missed Dose

If a dose of IMIGRAN 50mg Tablet 6s is missed, take the dose as soon as you remember it. If it is almost the time for the next dose, skip the missed dose and take the next dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Fluvoxamine   (severe)

Ondansetron   (severe)

Almotriptan   (moderate)

Nefazodone   (moderate)

Prescribes

Migraine Headache

This medicine is used to relieve symptoms of a migraine headache.

Cluster headache

This medicine is used to relieve symptoms of a cluster headache.

Side Effects

Chest pain   (severe)

Drowsiness   (severe)

Dizziness   (severe)

Shortness of breath   (severe)

Feeling of warmth or heat   (severe)

Irregular heartbeat   (severe)

Itching   (severe)

Numbness   (severe)

Dry mouth  

Nausea and Vomiting  

Unusual tiredness and weakness  

Warnings

High cholesterol

Liver diseases

Seizure disorder

Wolff-Parkinson-White Syndrome

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to IMIGRAN 50mg Tablet 6s .

Cardiovascular Disease

This medicine is not recommended for use in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition.

Uncontrolled hypertension

This medicine is not recommended for use in patients with a history of uncontrolled hypertension due to the increased risk of very high blood pressure and hypertensive crisis.

Peripheral vascular diseases

This medicine is not recommended for use in patients with a known history of peripheral vascular diseases due to the increased risk of worsening of the patient's condition.

Monoamine oxidase inhibitors (MAOI)

This medicine is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of a life-threatening condition called Serotonin Syndrome. A time gap of at least 14 days should be maintained between stopping therapy with MAOIs and starting therapy with this medicine.

Severe liver impairment

This medicine is not recommended for use in patients with severe liver disease due to the increased risk of worsening of the patient's condition.